selected publications
-
academic article
-
Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
Clinical Chemistry and Laboratory Medicine.
57.
2018
Correction to: Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.
Diabetologia.
61.
2018
Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis.
Scandinavian Journal of Clinical and Laboratory Investigation.
78.
2018
FRI-399 Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients.
Journal of Hepatology.
68.
2018
High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study.
Orphanet Journal of Rare Diseases.
13.
2018
Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease.
Journal of Pediatric Gastroenterology and Nutrition.
67.
2018
Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial.
Endocrine Connections.
7.
2018
No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
PLoS ONE.
13.
2018
Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
Scandinavian Journal of Gastroenterology.
53.
2018
Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
Journal of Gastroenterology and Hepatology.
33.
2018
Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.
Alimentary Pharmacology & Therapeutics.
47.
2018
Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in Human Immunodeficiency Virus Infection..
The Journal of Infectious Diseases.
218.
2018
Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis.
Immunology and Cell Biology.
96.
2018
The Effect of Ethanol on Inflammation Markers and FGF-21 in Healthy Individuals.
Diabetes.
67.
2018
The macrophage activation marker sMR as a diagnostic and prognostic marker in patients with acute infectious disease with or without sepsis.
Scandinavian Journal of Clinical and Laboratory Investigation.
78.
2018
Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.
Molecular Therapy - Methods & Clinical Development.
4.
2017
Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.
Scandinavian Journal of Clinical and Laboratory Investigation.
77.
2017
Letter: autoimmune hepatitis—drug‐induced liver injury must always be excluded. Authors’ reply.
Alimentary Pharmacology & Therapeutics.
46.
2017
Loss of E-cadherin as Part of a Migratory Phenotype in Melanoma Is Associated With Ulceration.
American Journal of Dermatopathology.
39.
2017
Löslicher Mannose-Rezeptor und sCD163 bei PatientInnen mit Leberzirrhose als Biomarker für Mortalität und Auftreten von Komplikationen.
Zeitschrift für Gastroenterologie.
55.
2017
Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
Surgery for Obesity and Related Diseases.
13.
2017
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.
OncoTargets and Therapy.
10.
2017
Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection.
AIDS.
31.
2017
Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity.
Scandinavian Journal of Clinical and Laboratory Investigation.
77.
2017
Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma.
Scientific Reports.
7.
2017
The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.
PLoS ONE.
12.
2017
The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.
Liver International.
37.
2017
Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and tumor necrosis factor‐alpha.
Neurogastroenterology & Motility.
29.
2017
A multi‐biomarker follow‐up study of patients with multiple sclerosis.
Brain and Behavior.
6.
2016
Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease.
Digestive and Liver Disease.
48.
2016
Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis.
PLoS ONE.
11.
2016
Anti-CD163-dexamethasone conjugate inhibits the acute phase response to lipopolysaccharide in rats.
World Journal of Hepatology.
8.
2016
Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries: An experimental study in rats.
Hepato Pancreato Biliary.
18.
2016
Brief Report.
JAIDS Journal of Acquired Immune Deficiency Syndromes.
72.
2016
Editorial: measuring inflammatory and fibrotic components of portal hypertension – a non‐invasive hepatic venous pressure gradient? Authors’ reply.
Alimentary Pharmacology & Therapeutics.
44.
2016
Glucocorticoid receptor haplotypes conferring increased sensitivity (BclI and N363S) are associated with faster progression of multiple sclerosis.
Journal of Neuroimmunology.
299.
2016
Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.
Scandinavian Journal of Clinical and Laboratory Investigation.
76.
2016
Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
Journal of Hepatology.
64.
2016
PWE-001 Transcutaneous Cervical Vagal Nerve Stimulation Exerts an anti-TNF-Alpha Effect in Healthy Humans.
Gut.
65.
2016
Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease.
Scandinavian Journal of Gastroenterology.
51.
2016
Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1–Infected Individuals.
The Journal of Infectious Diseases.
214.
2016
Signs of low-grade systemic inflammation in female offspring of women with type 1 diabetes: The EPICOM study.
Diabetes & Metabolism.
42.
2016
Single‐centre experience of the macrophage activation marker soluble (s)CD163 – associations with disease activity and treatment response in patients with autoimmune hepatitis.
Alimentary Pharmacology & Therapeutics.
44.
2016
Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.
Diabetologia.
59.
2016
Testosterone Measured with an Automatic Immunoassay Compares Reasonably Well to Results Obtained by LC-MS/MS..
Clinical Laboratory.
62.
2016
The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis.
Alimentary Pharmacology & Therapeutics.
43.
2016
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease.
Liver International.
36.
2016
Urine sCD163: a window onto glomerular inflammation.
Nephrology,Dialysis and Transplantation.
31.
2016
Activation of Latent Human Immunodeficiency Virus by the Histone Deacetylase Inhibitor Panobinostat: A Pilot Study to Assess Effects on the Central Nervous System.
Open Forum Infectious Diseases.
2.
2015
Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver.
Annals of Medicine and Surgery.
4.
2015
Anti-inflammatory liposomes have no impact on liver regeneration in rats.
Annals of Medicine and Surgery.
4.
2015
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
PLoS ONE.
10.
2015
Consumption of the Epidermis.
American Journal of Dermatopathology.
37.
2015
Development of a high-resolution melting genotyping assay for the angiotensin I converting enzyme insertion/deletion polymorphism and establishment of genotype-specific reference intervals in a Danish population.
Annals of Clinical Biochemistry International Journal of Laboratory Medicine.
52.
2015
HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study.
Journal of Nuclear Cardiology.
22.
2015
Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival.
Infectious Diseases.
47.
2015
Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
Molecular Medicine.
21.
2015
Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux‐en‐Y gastric bypass.
Obesity.
23.
2015
LP21 : The macrophage activation markers soluble CD206 And CD163 predict mortality in patients with liver cirrhosis and acute-on-chronic liver failure (ACLF).
Journal of Hepatology.
62.
2015
Macrophage activation marker soluble CD163 and non‐alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Journal of Gastroenterology and Hepatology.
30.
2015
Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs..
Clinical and Experimental Rheumatology.
33.
2015
MelanA-negative spindle-cell associated melanoma, a distinct inflammatory phenotype correlated with dense infiltration of CD163 macrophages and loss of E-cadherin.
Melanoma Research.
25.
2015
P1055 : The macrophage activation marker soluble CD163 is independently associated with the severity of NAFLD in morbid obesity and reduced by bariatric surgery.
Journal of Hepatology.
62.
2015
P1061 : The macrophage activation marker SCD163 and the apoptosis marker cytokeratin-18 are both predictors of disease severity in patients with non-alcoholic fatty liver disease.
Journal of Hepatology.
62.
2015
P1070 : The marker of macrophage activation soluble CD163 is associated with liver histology in children with non-alcoholic fatty liver disease.
Journal of Hepatology.
62.
2015
Reply.
Hepatology.
61.
2015
Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia.
Leukemia & Lymphoma.
56.
2015
Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function.
Diabetic Medicine.
32.
2015
The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children.
Pediatric Obesity.
10.
2015
The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma.
Leukemia Research.
39.
2015
Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus.
Endocrine Connections.
4.
2015
A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness.
Clinical Chemistry and Laboratory Medicine.
52.
2014
Genotyping increases the yield of angiotensin-converting enzyme in sarcoidosis--a systematic review..
Danish Medical Journal.
61.
2014
Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study.
The American Journal of Gastroenterology.
109.
2014
Human Adipose Tissue Macrophages Are Enhanced but Changed to an Anti-Inflammatory Profile in Obesity.
Journal of Immunology Research.
2014.
2014
Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
European Journal of Clinical Microbiology & Infectious Diseases.
33.
2014
Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients.
PLoS ONE.
9.
2014
Monocyte/macrophage‐derived soluble CD163: a novel biomarker in multiple myeloma.
European Journal Of Haematology.
93.
2014
Prognostic Stratification of Ulcerated MelanomaNot Only the Extent Matters.
American Journal of Clinical Pathology.
142.
2014
Regulation of CD163 mRNA and soluble CD163 protein in human adipose tissue in vitro.
Journal of Molecular Endocrinology.
53.
2014
Relevance of sCD163 As a Prognostic Biomarker in Chronic B-Cell Lymphocytic Leukemia.
Blood.
124.
2014
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
PLoS ONE.
9.
2014
Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti‐TNF‐α Antibody Treatment in Active Inflammatory Bowel Disease.
Scandinavian Journal of Immunology.
80.
2014
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
Hepatology.
60.
2014
Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-α in Macrophages.
Journal of Biological Chemistry.
289.
2014
Wound-linked neutrophil re sponse associates with increased proliferation in ulcerated melanoma.
Journal of Plastic Reconstructive & Aesthetic Surgery.
67.
2014
-
chapter
-
Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease.
Springer Nature.
2017
-
dataset
-
25(OH)D3 and 1.25(OH)2D3 inhibits TNF-α expression in human monocyte derived macrophages.
public-library-of-science.
2019
Forward and reverse primers and annealing temperatures for RT-qPCR..
public-library-of-science.
2019
Demographic characteristics in the two groups (rifaximin-α and placebo) [24]..
public-library-of-science.
2018
Neoepitope markers of collagen remodeling before and after treatment..
public-library-of-science.
2018
No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
public-library-of-science.
2018
Multiple logistic regression analyses of the relationships between Clinically significant portal hypertension & sMR, CRP, GEC, and MELD-score..
public-library-of-science.
2017
Smr data.dta..
public-library-of-science.
2017
Study entry characteristics of patients with alcoholic hepatitis and patients with stable alcoholic liver cirrhosis and healthy persons (Data are median (interquartile range))..
public-library-of-science.
2017
Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis.
public-library-of-science.
2016
Baseline characteristics of the patients with alcoholic hepatitis and healthy controls..
public-library-of-science.
2016
Plasma hormone and glucose levels measured before (t = -60 min) and after intravenous alanine infusion (t = 360 min) in patients with alcoholic hepatitis and in healthy controls..
public-library-of-science.
2016
Biomarkers and their characteristics..
public-library-of-science.
2015
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
public-library-of-science.
2015
Demographic and clinical data of the patients with MS/CIS and SC..
public-library-of-science.
2015
Median levels and range of biomarkers in serum and CSF samples as determined by ELISA, for the patient groups..
public-library-of-science.
2015
Pearson pairwise correlation analysis without and with the Bonferroni correction of biomarkers: sCD163, CXCL13, NEO, NfL, and OPN..
public-library-of-science.
2015
Results from linear regression analyses of differences in levels of biomarkers between patients with MS/CIS and SC..
public-library-of-science.
2015
Spearman Correlation on categorical, nominal data and Pearson correlation on continuous data..
public-library-of-science.
2015
Data S1 - Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
public-library-of-science.
2014
Demographic data of the patients with MS/CIS and SC.
public-library-of-science.
2014
Median levels of sCD163 in serum and CSF samples as determined by ELISA..
public-library-of-science.
2014
Patient demographics..
public-library-of-science.
2014
Results from linear regression analyses of differences between patients with MS/CIS and SC..
public-library-of-science.
2014
SOFA score and biochemical variables during the study period..
public-library-of-science.
2014
-
hide from search
-
Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease.
taylor-&-francis-group.
2020
1342 CHANGE IN SOLUBLE CD163, A MARKER OF ACTIVATED MACROPHAGES, IS ASSOCIATED WITH IMPROVEMENT IN LIVER ENZYMES AND METABOLIC PROFILE IN OBESE CHILDREN DURING LIFESTYLE INTERVENTION.
Journal of Hepatology.
2013
Circulating Levels of the Shed Scavenger Receptor sCD163 and Association with Outcome of Critically Ill Patients.
Journal of Clinical Immunology.
2013
Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.
Gut.
2013
Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer.
Journal of Ovarian Research.
2013
Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case–control study.
BMC Infectious Diseases.
2013
Targeting Dexamethasone to Macrophages in a Porcine Endotoxemic Model.
Critical Care Medicine.
2013
The Macrophage‐Specific Serum Marker, Soluble CD163, Is Increased in Obesity and Reduced After Dietary‐Induced Weight Loss.
Obesity.
2013
The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids.
Endocrine Connections.
2013
-
patent